Prediction of primary resistance to anti-PD1 therapy (APD1) in second-line NSCLC

E. F. Smit; J. G. Aerts; M. Muller; A. L.N. Niemeijer; H. Roder; C. Oliveira; J. Roder

doi:https://doi.org/10.1093/annonc/mdy269.068

Prediction of primary resistance to anti-PD1 therapy (APD1) in second-line NSCLC

E. F. Smit, J. G. Aerts, M. Muller, A. L.N. Niemeijer, H. Roder, C. Oliveira, J. Roder

Pulmonary medicine (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	viii21
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy269.068
Publication status	Published - 1 Oct 2018

Access to Document

https://doi.org/10.1093/annonc/mdy269.068

Cite this

@article{4be7a4465ee2458eb23fe384d68a7f18,

title = "Prediction of primary resistance to anti-PD1 therapy (APD1) in second-line NSCLC",

author = "Smit, {E. F.} and Aerts, {J. G.} and M. Muller and Niemeijer, {A. L.N.} and H. Roder and C. Oliveira and J. Roder",

year = "2018",

month = oct,

day = "1",

doi = "https://doi.org/10.1093/annonc/mdy269.068",

language = "English",

volume = "29",

pages = "viii21",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Prediction of primary resistance to anti-PD1 therapy (APD1) in second-line NSCLC

AU - Smit, E. F.

AU - Aerts, J. G.

AU - Muller, M.

AU - Niemeijer, A. L.N.

AU - Roder, H.

AU - Oliveira, C.

AU - Roder, J.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85078829722&partnerID=8YFLogxK

U2 - https://doi.org/10.1093/annonc/mdy269.068

DO - https://doi.org/10.1093/annonc/mdy269.068

M3 - Article

C2 - 32136437

SN - 0923-7534

VL - 29

SP - viii21

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Prediction of primary resistance to anti-PD1 therapy (APD1) in second-line NSCLC

Access to Document

Other files and links

Cite this